UniProt ID | SNW1_HUMAN | |
---|---|---|
UniProt AC | Q13573 | |
Protein Name | SNW domain-containing protein 1 | |
Gene Name | SNW1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 536 | |
Subcellular Localization | Nucleus . | |
Protein Description | Involved in pre-mRNA splicing as component of the spliceosome. [PubMed: 11991638] | |
Protein Sequence | MALTSFLPAPTQLSQDQLEAEEKARSQRSRQTSLVSSRREPPPYGYRKGWIPRLLEDFGDGGAFPEIHVAQYPLDMGRKKKMSNALAIQVDSEGKIKYDAIARQGQSKDKVIYSKYTDLVPKEVMNADDPDLQRPDEEAIKEITEKTRVALEKSVSQKVAAAMPVRAADKLAPAQYIRYTPSQQGVAFNSGAKQRVIRMVEMQKDPMEPPRFKINKKIPRGPPSPPAPVMHSPSRKMTVKEQQEWKIPPCISNWKNAKGYTIPLDKRLAADGRGLQTVHINENFAKLAEALYIADRKAREAVEMRAQVERKMAQKEKEKHEEKLREMAQKARERRAGIKTHVEKEDGEARERDEIRHDRRKERQHDRNLSRAAPDKRSKLQRNENRDISEVIALGVPNPRTSNEVQYDQRLFNQSKGMDSGFAGGEDEIYNVYDQAWRGGKDMAQSIYRPSKNLDKDMYGDDLEARIKTNRFVPDKEFSGSDRRQRGREGPVQFEEDPFGLDKFLEEAKQHGGSKRPSDSSRPKEHEHEGKKRRKE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MALTSFLPA ------CCCCCCCCC | 21.39 | 22223895 | |
4 | Phosphorylation | ----MALTSFLPAPT ----CCCCCCCCCCC | 14.11 | 30108239 | |
5 | Phosphorylation | ---MALTSFLPAPTQ ---CCCCCCCCCCCC | 26.15 | 28464451 | |
11 | Phosphorylation | TSFLPAPTQLSQDQL CCCCCCCCCCCHHHH | 44.22 | 23663014 | |
14 | Phosphorylation | LPAPTQLSQDQLEAE CCCCCCCCHHHHHHH | 23.15 | 25159151 | |
23 | Sumoylation | DQLEAEEKARSQRSR HHHHHHHHHHHHHHH | 40.37 | 28112733 | |
29 | Phosphorylation | EKARSQRSRQTSLVS HHHHHHHHHHHHHHC | 22.54 | 26434776 | |
32 | Phosphorylation | RSQRSRQTSLVSSRR HHHHHHHHHHHCCCC | 23.95 | 28450419 | |
33 | Phosphorylation | SQRSRQTSLVSSRRE HHHHHHHHHHCCCCC | 20.59 | 23911959 | |
36 | Phosphorylation | SRQTSLVSSRREPPP HHHHHHHCCCCCCCC | 24.34 | 26552605 | |
37 | Phosphorylation | RQTSLVSSRREPPPY HHHHHHCCCCCCCCC | 28.07 | 26552605 | |
46 | Phosphorylation | REPPPYGYRKGWIPR CCCCCCCCCCCCHHH | 11.87 | - | |
72 | Phosphorylation | PEIHVAQYPLDMGRK CCEEEEEEECCCCCC | 8.95 | - | |
81 | Sumoylation | LDMGRKKKMSNALAI CCCCCCCCCCCCEEE | 51.07 | - | |
81 | Sumoylation | LDMGRKKKMSNALAI CCCCCCCCCCCCEEE | 51.07 | 28112733 | |
82 | Sulfoxidation | DMGRKKKMSNALAIQ CCCCCCCCCCCEEEE | 5.26 | 21406390 | |
83 | Phosphorylation | MGRKKKMSNALAIQV CCCCCCCCCCEEEEE | 28.03 | 23911959 | |
92 | Phosphorylation | ALAIQVDSEGKIKYD CEEEEECCCCCEEHH | 49.76 | 21815630 | |
97 | Sumoylation | VDSEGKIKYDAIARQ ECCCCCEEHHHHHCC | 40.33 | - | |
97 | Acetylation | VDSEGKIKYDAIARQ ECCCCCEEHHHHHCC | 40.33 | 25953088 | |
97 | Sumoylation | VDSEGKIKYDAIARQ ECCCCCEEHHHHHCC | 40.33 | 25772364 | |
97 | Ubiquitination | VDSEGKIKYDAIARQ ECCCCCEEHHHHHCC | 40.33 | - | |
98 | Phosphorylation | DSEGKIKYDAIARQG CCCCCEEHHHHHCCC | 17.68 | 28796482 | |
110 | Acetylation | RQGQSKDKVIYSKYT CCCCCCCCEEEEECC | 33.98 | 26051181 | |
113 | Phosphorylation | QSKDKVIYSKYTDLV CCCCCEEEEECCCCC | 11.33 | 22817900 | |
114 | Phosphorylation | SKDKVIYSKYTDLVP CCCCEEEEECCCCCC | 14.20 | - | |
115 | Acetylation | KDKVIYSKYTDLVPK CCCEEEEECCCCCCH | 34.89 | 19608861 | |
115 | Sumoylation | KDKVIYSKYTDLVPK CCCEEEEECCCCCCH | 34.89 | 28112733 | |
116 | Phosphorylation | DKVIYSKYTDLVPKE CCEEEEECCCCCCHH | 10.27 | 28796482 | |
117 | Phosphorylation | KVIYSKYTDLVPKEV CEEEEECCCCCCHHH | 26.96 | 24719451 | |
122 | Acetylation | KYTDLVPKEVMNADD ECCCCCCHHHCCCCC | 56.30 | 7962677 | |
122 | Sumoylation | KYTDLVPKEVMNADD ECCCCCCHHHCCCCC | 56.30 | 28112733 | |
125 | Sulfoxidation | DLVPKEVMNADDPDL CCCCHHHCCCCCCCC | 3.43 | 21406390 | |
141 | Sumoylation | RPDEEAIKEITEKTR CCCHHHHHHHHHHHH | 50.54 | 28112733 | |
146 | 2-Hydroxyisobutyrylation | AIKEITEKTRVALEK HHHHHHHHHHHHHHH | 32.74 | - | |
153 | 2-Hydroxyisobutyrylation | KTRVALEKSVSQKVA HHHHHHHHHHHHHHH | 57.94 | - | |
153 | Acetylation | KTRVALEKSVSQKVA HHHHHHHHHHHHHHH | 57.94 | 23749302 | |
153 | Ubiquitination | KTRVALEKSVSQKVA HHHHHHHHHHHHHHH | 57.94 | - | |
158 | Acetylation | LEKSVSQKVAAAMPV HHHHHHHHHHHCCCC | 26.74 | 25953088 | |
158 | Sumoylation | LEKSVSQKVAAAMPV HHHHHHHHHHHCCCC | 26.74 | 28112733 | |
170 | Sumoylation | MPVRAADKLAPAQYI CCCHHHHHCCCHHHE | 41.65 | - | |
170 | 2-Hydroxyisobutyrylation | MPVRAADKLAPAQYI CCCHHHHHCCCHHHE | 41.65 | - | |
170 | Acetylation | MPVRAADKLAPAQYI CCCHHHHHCCCHHHE | 41.65 | 23954790 | |
170 | Sumoylation | MPVRAADKLAPAQYI CCCHHHHHCCCHHHE | 41.65 | 28112733 | |
170 | Ubiquitination | MPVRAADKLAPAQYI CCCHHHHHCCCHHHE | 41.65 | - | |
176 | Phosphorylation | DKLAPAQYIRYTPSQ HHCCCHHHEEECHHH | 6.89 | 17360941 | |
178 | Methylation | LAPAQYIRYTPSQQG CCCHHHEEECHHHCC | 25.08 | 115917025 | |
179 | Phosphorylation | APAQYIRYTPSQQGV CCHHHEEECHHHCCC | 17.28 | 28152594 | |
180 | Phosphorylation | PAQYIRYTPSQQGVA CHHHEEECHHHCCCC | 13.45 | 21815630 | |
182 | Phosphorylation | QYIRYTPSQQGVAFN HHEEECHHHCCCCCC | 27.60 | 28152594 | |
190 | Phosphorylation | QQGVAFNSGAKQRVI HCCCCCCCCCCHHHH | 33.40 | 21815630 | |
193 | Sumoylation | VAFNSGAKQRVIRMV CCCCCCCCHHHHHHH | 42.01 | - | |
193 | Acetylation | VAFNSGAKQRVIRMV CCCCCCCCHHHHHHH | 42.01 | 25953088 | |
193 | Sumoylation | VAFNSGAKQRVIRMV CCCCCCCCHHHHHHH | 42.01 | 28112733 | |
193 | Ubiquitination | VAFNSGAKQRVIRMV CCCCCCCCHHHHHHH | 42.01 | - | |
199 | Sulfoxidation | AKQRVIRMVEMQKDP CCHHHHHHHHCCCCC | 1.74 | 21406390 | |
204 | Acetylation | IRMVEMQKDPMEPPR HHHHHCCCCCCCCCC | 63.59 | 12429925 | |
213 | Acetylation | PMEPPRFKINKKIPR CCCCCCCCCCCCCCC | 46.80 | 19608861 | |
224 | Phosphorylation | KIPRGPPSPPAPVMH CCCCCCCCCCCCCCC | 46.80 | 29255136 | |
232 | Phosphorylation | PPAPVMHSPSRKMTV CCCCCCCCCCCCCCH | 13.38 | 29255136 | |
234 | Phosphorylation | APVMHSPSRKMTVKE CCCCCCCCCCCCHHH | 47.77 | 29255136 | |
238 | Phosphorylation | HSPSRKMTVKEQQEW CCCCCCCCHHHHHCC | 31.31 | 26074081 | |
240 | Sumoylation | PSRKMTVKEQQEWKI CCCCCCHHHHHCCCC | 40.41 | - | |
240 | Sumoylation | PSRKMTVKEQQEWKI CCCCCCHHHHHCCCC | 40.41 | 28112733 | |
240 | Ubiquitination | PSRKMTVKEQQEWKI CCCCCCHHHHHCCCC | 40.41 | - | |
246 | Ubiquitination | VKEQQEWKIPPCISN HHHHHCCCCCCCCCC | 44.58 | - | |
255 | Ubiquitination | PPCISNWKNAKGYTI CCCCCCCCCCCCCEE | 51.80 | - | |
258 | Sumoylation | ISNWKNAKGYTIPLD CCCCCCCCCCEEECC | 62.94 | 28112733 | |
258 | Ubiquitination | ISNWKNAKGYTIPLD CCCCCCCCCCEEECC | 62.94 | - | |
260 | Phosphorylation | NWKNAKGYTIPLDKR CCCCCCCCEEECCHH | 10.78 | 30257219 | |
261 | Phosphorylation | WKNAKGYTIPLDKRL CCCCCCCEEECCHHH | 25.45 | 23403867 | |
266 | Acetylation | GYTIPLDKRLAADGR CCEEECCHHHCCCCC | 57.93 | 25953088 | |
266 | Ubiquitination | GYTIPLDKRLAADGR CCEEECCHHHCCCCC | 57.93 | - | |
273 | Methylation | KRLAADGRGLQTVHI HHHCCCCCCCCEEEC | 43.10 | 115917029 | |
277 | Phosphorylation | ADGRGLQTVHINENF CCCCCCCEEECCHHH | 21.06 | 28555341 | |
286 | Sumoylation | HINENFAKLAEALYI ECCHHHHHHHHHHHH | 44.06 | 28112733 | |
292 | Phosphorylation | AKLAEALYIADRKAR HHHHHHHHHHCHHHH | 10.91 | 21945579 | |
315 | Acetylation | VERKMAQKEKEKHEE HHHHHHHHHHHHHHH | 62.30 | 19818653 | |
317 | Acetylation | RKMAQKEKEKHEEKL HHHHHHHHHHHHHHH | 78.19 | 19818663 | |
339 | Sumoylation | RERRAGIKTHVEKED HHHHHCCCCCEECCC | 31.49 | - | |
339 | Sumoylation | RERRAGIKTHVEKED HHHHHCCCCCEECCC | 31.49 | 28112733 | |
340 | Phosphorylation | ERRAGIKTHVEKEDG HHHHCCCCCEECCCC | 29.27 | - | |
344 | Sumoylation | GIKTHVEKEDGEARE CCCCCEECCCCCHHC | 61.08 | 28112733 | |
370 | Phosphorylation | RQHDRNLSRAAPDKR HHHHHHHHHHCCCHH | 24.34 | 30266825 | |
389 | Phosphorylation | RNENRDISEVIALGV HHCCCCHHHHHHCCC | 30.05 | 27174698 | |
401 | O-linked_Glycosylation | LGVPNPRTSNEVQYD CCCCCCCCCCCHHHH | 36.84 | 23301498 | |
401 | Phosphorylation | LGVPNPRTSNEVQYD CCCCCCCCCCCHHHH | 36.84 | 28450419 | |
402 | Phosphorylation | GVPNPRTSNEVQYDQ CCCCCCCCCCHHHHH | 32.07 | 21815630 | |
407 | Phosphorylation | RTSNEVQYDQRLFNQ CCCCCHHHHHHHHHH | 21.15 | 28796482 | |
410 | Methylation | NEVQYDQRLFNQSKG CCHHHHHHHHHHCCC | 38.05 | 115917033 | |
416 | Sumoylation | QRLFNQSKGMDSGFA HHHHHHCCCCCCCCC | 48.79 | 28112733 | |
416 | Ubiquitination | QRLFNQSKGMDSGFA HHHHHHCCCCCCCCC | 48.79 | - | |
418 | Sulfoxidation | LFNQSKGMDSGFAGG HHHHCCCCCCCCCCC | 4.21 | 30846556 | |
420 | Phosphorylation | NQSKGMDSGFAGGED HHCCCCCCCCCCCCH | 27.24 | 28348404 | |
430 | Phosphorylation | AGGEDEIYNVYDQAW CCCCHHHHHHHHHHH | 9.13 | 25884760 | |
433 | Phosphorylation | EDEIYNVYDQAWRGG CHHHHHHHHHHHCCC | 9.94 | 28796482 | |
438 | Methylation | NVYDQAWRGGKDMAQ HHHHHHHCCCHHHHH | 47.18 | 54559331 | |
441 | Acetylation | DQAWRGGKDMAQSIY HHHHCCCHHHHHHHH | 47.34 | 23749302 | |
441 | Sumoylation | DQAWRGGKDMAQSIY HHHHCCCHHHHHHHH | 47.34 | 28112733 | |
441 | Ubiquitination | DQAWRGGKDMAQSIY HHHHCCCHHHHHHHH | 47.34 | - | |
446 | Phosphorylation | GGKDMAQSIYRPSKN CCHHHHHHHHCCCCC | 16.43 | 21945579 | |
448 | Nitration | KDMAQSIYRPSKNLD HHHHHHHHCCCCCCC | 23.01 | - | |
448 | Phosphorylation | KDMAQSIYRPSKNLD HHHHHHHHCCCCCCC | 23.01 | 21945579 | |
451 | Phosphorylation | AQSIYRPSKNLDKDM HHHHHCCCCCCCCCC | 25.77 | 21945579 | |
452 | Sumoylation | QSIYRPSKNLDKDMY HHHHCCCCCCCCCCC | 65.30 | 28112733 | |
456 | Acetylation | RPSKNLDKDMYGDDL CCCCCCCCCCCCCHH | 47.78 | 25953088 | |
456 | Ubiquitination | RPSKNLDKDMYGDDL CCCCCCCCCCCCCHH | 47.78 | - | |
459 | Phosphorylation | KNLDKDMYGDDLEAR CCCCCCCCCCHHHHH | 27.77 | 29978859 | |
469 | O-linked_Glycosylation | DLEARIKTNRFVPDK HHHHHHHCCCCCCCC | 29.29 | 23301498 | |
476 | 2-Hydroxyisobutyrylation | TNRFVPDKEFSGSDR CCCCCCCCCCCCCCH | 55.37 | - | |
476 | Acetylation | TNRFVPDKEFSGSDR CCCCCCCCCCCCCCH | 55.37 | 25953088 | |
476 | Ubiquitination | TNRFVPDKEFSGSDR CCCCCCCCCCCCCCH | 55.37 | - | |
479 | Phosphorylation | FVPDKEFSGSDRRQR CCCCCCCCCCCHHHC | 38.18 | 23401153 | |
481 | Phosphorylation | PDKEFSGSDRRQRGR CCCCCCCCCHHHCCC | 27.09 | 28112733 | |
503 | Ubiquitination | EDPFGLDKFLEEAKQ CCCCCHHHHHHHHHH | 57.82 | - | |
509 | Sumoylation | DKFLEEAKQHGGSKR HHHHHHHHHCCCCCC | 46.22 | - | |
509 | Sumoylation | DKFLEEAKQHGGSKR HHHHHHHHHCCCCCC | 46.22 | 28112733 | |
509 | Ubiquitination | DKFLEEAKQHGGSKR HHHHHHHHHCCCCCC | 46.22 | - | |
518 | Phosphorylation | HGGSKRPSDSSRPKE CCCCCCCCCCCCCCC | 54.91 | 26055452 | |
520 | Phosphorylation | GSKRPSDSSRPKEHE CCCCCCCCCCCCCCC | 32.36 | 20068231 | |
521 | Phosphorylation | SKRPSDSSRPKEHEH CCCCCCCCCCCCCCC | 58.56 | 20068231 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SNW1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SNW1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-224; SER-232 AND SER-234, AND MASSSPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-115, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-224 AND SER-232, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-224; SER-232 AND SER-234, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-224 AND SER-232, ANDMASS SPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-224 AND SER-234, ANDMASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-224; SER-232 ANDSER-234, AND MASS SPECTROMETRY. | |
"Toward a global characterization of the phosphoproteome in prostatecancer cells: identification of phosphoproteins in the LNCaP cellline."; Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.; Electrophoresis 28:2027-2034(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-224 AND SER-232, ANDMASS SPECTROMETRY. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-224 AND SER-232, ANDMASS SPECTROMETRY. |